Jérôme Legoff

Author PubWeight™ 17.09‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Impact of acyclovir on genital and plasma HIV-1 RNA, genital herpes simplex virus type 2 DNA, and ulcer healing among HIV-1-infected African women with herpes ulcers: a randomized placebo-controlled trial. J Infect Dis 2009 1.14
2 Fully automated quantification of cytomegalovirus (CMV) in whole blood with the new sensitive Abbott RealTime CMV assay in the era of the CMV international standard. J Clin Microbiol 2013 1.08
3 Genital shedding of herpes simplex virus-2 DNA and HIV-1 RNA and proviral DNA in HIV-1- and herpes simplex virus-2-coinfected African women. J Acquir Immune Defic Syndr 2003 1.03
4 Independent levels of cell-free and cell-associated human immunodeficiency virus-1 in genital-tract secretions of clinically asymptomatic, treatment-naive African women. J Infect Dis 2003 1.00
5 Opsonization of HIV with complement enhances infection of dendritic cells and viral transfer to CD4 T cells in a CR3 and DC-SIGN-dependent manner. J Immunol 2007 0.95
6 Comparison of washing and swabbing procedures for collecting genital fluids to assess cervicovaginal shedding of herpes simplex virus type 2 DNA. J Clin Microbiol 2003 0.86
7 Genital shedding of herpes simplex virus type 2 in childbearing-aged and pregnant women living in Gabon. Int J STD AIDS 2006 0.83
8 Risk factors for pneumonia in immunocompromised patients with influenza. Respir Med 2010 0.82
9 Epidemiological and clinical characteristics of patients infected with enterovirus D68, France, July to December 2014. Euro Surveill 2016 0.82
10 Burden of respiratory viruses in patients with acute respiratory failure. J Med Virol 2013 0.81
11 Virological diagnosis of central nervous system infections by use of PCR coupled with mass spectrometry analysis of cerebrospinal fluid samples. J Clin Microbiol 2013 0.80
12 Mucosal humoral immune response to hepatitis C virus E1/E2 surface glycoproteins and HCV shedding in saliva and cervicovaginal fluids from chronically HCV-infected patients. J Hepatol 2003 0.80
13 High seroprevalence of herpes simplex virus type 2 infection in French human immunodeficiency virus type 1-infected outpatients. J Clin Microbiol 2005 0.80
14 Molecular detection of respiratory viruses in immunocopromised ICU patients: incidence and meaning. Respir Med 2012 0.77
15 Cervicovaginal neutralizing antibodies to herpes simplex virus (HSV) in women seropositive for HSV Types 1 and 2. Clin Diagn Lab Immunol 2003 0.77
16 Cell-associated, non-replicating strand(+) hepatitis C virus-RNA shedding in cervicovaginal secretions from chronically HCV-infected women. J Clin Virol 2003 0.77
17 Epstein-Barr virus load in whole blood correlates with HIV surrogate markers and lymphoma: a French national cross-sectional study. J Acquir Immune Defic Syndr 2009 0.77
18 Sustained high proportion of zidovudine-resistant HIV variants despite prolonged substitution of zidovudine by other nucleoside reverse transcriptase inhibitors. J Med Virol 2002 0.77
19 Peptide insertions in reverse transcriptase pol gene of human immunodeficiency virus type 1 as a rare cause of persistent antiretroviral therapeutic failure. Clin Microbiol Infect 2004 0.76
20 Human Herpesvirus-6 cytopathic inclusions: an exceptional and recognizable finding on skin biopsy during HHV6 reactivation after autologous stem-cell transplantation. Am J Dermatopathol 2012 0.76
21 Low seroprevalence of herpes simplex virus type 2 among pregnant women in Senegal. Int J STD AIDS 2008 0.75